BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34532454)

  • 1. DAB2IP decreases cell growth and migration and increases sensitivity to chemotherapeutic drugs in colorectal cancer.
    Wu G; Xu X; Wan D; Zhou D; Feng Y; Chen J; Peng Z; Fang D; Shi X; Yao H; Chen G; Sun L; Yao Y; Zhou G; Yang Y; He S
    Ann Transl Med; 2021 Aug; 9(16):1317. PubMed ID: 34532454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation.
    Zhou Y; Yang Z; Zhang H; Li H; Zhang M; Wang H; Zhang M; Qiu P; Zhang R; Liu J
    Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166353. PubMed ID: 35063646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-889 promotes cell proliferation in colorectal cancer by targeting DAB2IP.
    Xiao Y; Li ZH; Bi YH
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3326-3334. PubMed ID: 31081086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-182 contributes to cell proliferation, invasion and tumor growth in colorectal cancer by targeting DAB2IP.
    Li X; Zhang X; Zhang Q; Lin R
    Int J Biochem Cell Biol; 2019 Jun; 111():27-36. PubMed ID: 30974224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer.
    Wang J; Zhu X; Hu J; He G; Li X; Wu P; Ren X; Wang F; Liao W; Liang L; Ding Y
    Oncotarget; 2015 Sep; 6(29):27427-39. PubMed ID: 26336990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of FAT4 enhances the chemosensitivity of colorectal cancer cells treated by 5-FU.
    Li Q; Zhou X; Fang Z; Pan Z; Zhou H
    Transl Cancer Res; 2020 Jan; 9(1):309-322. PubMed ID: 35117185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells.
    Duan Y; Yin X; Lai X; Liu C; Nie W; Li D; Xie Z; Li Z; Meng F
    Technol Cancer Res Treat; 2020; 19():1533033819895494. PubMed ID: 32336215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway.
    Sun L; Yao Y; Lu T; Shang Z; Zhan S; Shi W; Pan G; Zhu X; He S
    Gastroenterol Res Pract; 2018; 2018():2968252. PubMed ID: 29743885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer.
    Min J; Liu L; Li X; Jiang J; Wang J; Zhang B; Cao D; Yu D; Tao D; Hu J; Gong J; Xie D
    Sci Rep; 2015 Nov; 5():16578. PubMed ID: 26564738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAB2IP-knocking down resulted in radio-resistance of breast cancer cells is associated with increased hypoxia and vasculogenic mimicry formation.
    Zhang X; Wang Q; Zhang R; Kong Z
    Int J Radiat Biol; 2023; 99(10):1595-1606. PubMed ID: 36947637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer.
    Shen YJ; Kong ZL; Wan FN; Wang HK; Bian XJ; Gan HL; Wang CF; Ye DW
    Cancer Sci; 2014 Jun; 105(6):704-12. PubMed ID: 24684735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer.
    Wang G; Wang X; Han M; Wang X
    Onco Targets Ther; 2021; 14():979-988. PubMed ID: 33603402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2.
    Zhu XH; Wang JM; Yang SS; Wang FF; Hu JL; Xin SN; Men H; Lu GF; Lan XL; Zhang D; Wang XY; Liao WT; Ding YQ; Liang L
    Int J Cancer; 2017 Jul; 141(1):172-183. PubMed ID: 28335083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAB2IP with tumor-inhibiting activities exhibits frameshift mutations in gastrointestinal cancers.
    Son HJ; Jo YS; Kim MS; Yoo NJ; Lee SH
    Pathol Res Pract; 2018 Dec; 214(12):2075-2080. PubMed ID: 30477644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer.
    Zhang M; Peng Y; Yang Z; Zhang H; Xu C; Liu L; Zhao Q; Wu J; Wang H; Liu J
    BMC Cancer; 2022 May; 22(1):561. PubMed ID: 35590292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
    Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 Suppression Improved the Chemosensitivity of HT-29 Colorectal Cancer Cells to 5-Fluorouracil and Inhibited Cell Migration.
    Najafi S; Rahimi Z; Mansoori B; Mohammadi A; Mohammadnejad F; Amini M; Mokhtazadeh A; Asadzadeh Z; Chi-Shing Cho W; Baradaran B
    Adv Pharm Bull; 2023 Jul; 13(3):551-562. PubMed ID: 37646068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of DAB2IP promotes mesenchymal-to-neuroepithelial transition and neuronal differentiation of human mesenchymal stem cells.
    Chang SL; Chou RH; Zeng HJ; Lin YH; Chiu TY; Yang DM; Hung SC; Lai CH; Hsieh JT; Shyu WC; Yu YL
    PLoS One; 2013; 8(9):e75884. PubMed ID: 24073285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.